Friday, January 9, 2009

Gardasil again denied approval for women 27-45

US health regulators have again withheld approval for the use of Merck & Co's (MRK.N) Gardasil cervical cancer vaccine by women aged 27 to 45, asking for longer-term data on a test group, the drugmaker said on Friday.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)